Active	Status	Sponsor type	Region	Phase	Filter
7 Active 10 Inactive 17 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Plummer, Ruth
TebeMRD, NCT05315258: Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma	Recruiting	2	850	Europe	Tebentafusp, IMCgp100	University of Oxford, Immunocore Ltd, Natera, Inc.	Melanoma (Skin), Melanoma, Uveal	06/25	06/26
NCT04785365: Long-Term Follow-Up Study of Patients Receiving ATL001	Terminated	2	1	Europe	Biological: ATL001	Achilles Therapeutics UK Limited	Melanoma, Advanced Non Small Cell Lung Cancer	10/23	10/23
MIV-818-101, NCT03781934 / 2018-000995-14: A Study to Evaluate MIV-818 in Patients with Liver Cancer Manifestations	Active, not recruiting	1/2	53	Europe, RoW	MIV-818 (fostroxacitabine bralpamide) + pembrolizumab, MIV-818 (fostroxacitabine bralpamide) + lenvatinib	Medivir	Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Liver Metastases	01/25	06/25
NCT03568656 / 2018-000285-10: Study to Evaluate CCS1477 in Advanced Tumours	Active, not recruiting	1/2	350	Europe, US	CCS1477, Abiraterone acetate, Enzalutamide, Darolutamide, Olaparib, Atezolizumab	CellCentric Ltd.	Metastatic Castration-Resistant Prostate Cancer, Metastatic Breast Cancer, Non-small Cell Lung Cancer, Advanced Solid Tumors	08/25	08/25
NCT03892018: The Effect of Food on the Pharmacokinetics of Paclitaxel Administered Orally as Oraxol	Terminated	1	29	Europe	Oraxol, Paclitaxel and HM30181AK-US	Athenex, Inc.	Solid Tumor, Adult	05/23	05/23
NCT03447470 / 2017-000720-98: Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies	Completed	1	46	Europe	RXC004, Nivolumab	Redx Pharma Ltd	Cancer, Solid Tumor	09/23	09/23
ACT, NCT04021277: PS101-mediated With Chemotherapy in Liver Metastases From Cancer of Gastrointestinal Origin	Terminated	1	11	Europe	20 uL/kg PS101, 40 uL/kg PS101, Ultrasound	EXACT Therapeutics AS	Solid Tumor, Colorectal Cancer	08/24	09/24

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Plummer, Ruth
TebeMRD, NCT05315258: Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma	Recruiting	2	850	Europe	Tebentafusp, IMCgp100	University of Oxford, Immunocore Ltd, Natera, Inc.	Melanoma (Skin), Melanoma, Uveal	06/25	06/26
NCT04785365: Long-Term Follow-Up Study of Patients Receiving ATL001	Terminated	2	1	Europe	Biological: ATL001	Achilles Therapeutics UK Limited	Melanoma, Advanced Non Small Cell Lung Cancer	10/23	10/23
MIV-818-101, NCT03781934 / 2018-000995-14: A Study to Evaluate MIV-818 in Patients with Liver Cancer Manifestations	Active, not recruiting	1/2	53	Europe, RoW	MIV-818 (fostroxacitabine bralpamide) + pembrolizumab, MIV-818 (fostroxacitabine bralpamide) + lenvatinib	Medivir	Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Liver Metastases	01/25	06/25
NCT03568656 / 2018-000285-10: Study to Evaluate CCS1477 in Advanced Tumours	Active, not recruiting	1/2	350	Europe, US	CCS1477, Abiraterone acetate, Enzalutamide, Darolutamide, Olaparib, Atezolizumab	CellCentric Ltd.	Metastatic Castration-Resistant Prostate Cancer, Metastatic Breast Cancer, Non-small Cell Lung Cancer, Advanced Solid Tumors	08/25	08/25
NCT03892018: The Effect of Food on the Pharmacokinetics of Paclitaxel Administered Orally as Oraxol	Terminated	1	29	Europe	Oraxol, Paclitaxel and HM30181AK-US	Athenex, Inc.	Solid Tumor, Adult	05/23	05/23
NCT03447470 / 2017-000720-98: Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies	Completed	1	46	Europe	RXC004, Nivolumab	Redx Pharma Ltd	Cancer, Solid Tumor	09/23	09/23
ACT, NCT04021277: PS101-mediated With Chemotherapy in Liver Metastases From Cancer of Gastrointestinal Origin	Terminated	1	11	Europe	20 uL/kg PS101, 40 uL/kg PS101, Ultrasound	EXACT Therapeutics AS	Solid Tumor, Colorectal Cancer	08/24	09/24